TIRVA ROBERT L. (Interim CFO) sold 3.1% of their position (9.90K shares) of DNA X, INC. on the open market
Open‑market sale worth $5.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/15/2022ACC: 0000899243-22-026172
-9.90K
Net shares
Net seller
$5.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.18K
Price / share
$0.54
Trade value
$4.99K
% of position
2.8%
7/13/2022
324.52K→315.35K
Common Stock
Direct
Shares
−729.00
Price / share
$0.76
Trade value
$553.09
% of position
0.2%
7/15/2022
315.35K→314.62K
Total
Net shares
−9.90K
Net value
-$5.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/13/2022 | S · Sale | −9.18K | $0.54 | $4.99K | 2.8% | 324.52K | 315.35K |
| Common Stock Direct | 7/15/2022 | S · Sale | −729.00 | $0.76 | $553.09 | 0.2% | 315.35K | 314.62K |
| Total | −9.90K | -$5.54K | ||||||
Derivative Transactions0
No derivative transactions reported